Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook

October 27, 2020 6:49 AM

Merck (NYSE: MRK) reported Q3 EPS of $1.74, $0.31 better than the analyst estimate of $1.43. Revenue for the quarter came in at $12.6 billion versus the consensus estimate of $12.17 billion.


Merck sees FY2020 EPS of $5.91-$6.01, versus the consensus of $5.71. Merck sees FY2020 revenue of $47.6-48.6 billion, versus the consensus of $48 billion.

For earnings history and earnings-related data on Merck (MRK) click here.


Corporate News Earnings Guidance Hot Guidance Management Comments

Next Articles